Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Trump Applauds SoftBank Investment, Targets High Drug Prices

Published 12/09/2016, 04:34 AM
Updated 07/09/2023, 06:31 AM

On today’s episode of the Zacks Friday Finish Line podcast, Content Writer Ryan McQueeney and Editor Maddy Johnson take on this week’s biggest story: Donald Trump’s latest round of deals and promises.

The hosts kicked the show off with a look at Starbuck (NYSE:S) . The company appears to be doubling down on its premium offerings and has pledged a significant expansion of its “Roastery” and “Reserve” concepts. Co-founder Howard Schultz will be stepping down from his role as his CEO to focus on promoting the new brands.

Find out more here: Starbucks (NASDAQ:SBUX) News: $10 Coffee, Its Next Five Years, Princi is a Go

Next up was the news that Apple’s (NASDAQ:AAPL) Apple Music streaming service has hit 20 million paying subscribers. In just a year and a half, Apple has accumulated nearly half the number of subscribers that Spotify has in about eight years. We’ve truly reached a key moment for the music streaming industry.

More details here: Apple Music Achieves 20 Million Paying Subscribers

Maddy and Ryan also touched on a few earnings reports from this week, including Lululemon (NASDAQ:LULU) , Costco (NYSE:S) , and Dave and Buster’s (NASDAQ:PLAY) , which sparked a discussion on why the arcade-restaurant concept has performed so well this year.

More on Dave and Buster’s: Dave & Buster's Just Hit a New 52-Week High

Finally, this week’s top story was more news from President-elect Donald Trump. The perpetual deal maker was at it again this week, this time teaming up with SoftBank (NYSE:S) to announce a $50 billion investment in the United States that will potentially create 50,000 new jobs. The announcement sent SoftBank and Sprint (NYSE:S) , which is 82%-owned by SoftBank, soaring this week.

Trump also sent biotech investors into a selling frenzy on Wednesday when he told Time, which just declared him “Person of the Year,” that he would target high drug price hikes.

Find out more on both stories here: SoftBank and Sprint Soaring on Trump-backed Investment Plan & Trump Vows to Slash Drug Prices, Sends Biotech Stocks Lower

As always, thanks for checking out this week’s episode of the Zacks Friday Finish Line, and make sure to check back next week for even more news from the investment and financial world!

Stocks that Aren't in the News. Yet.

You are invited to download the full, up-to-the-minute list of 220 Zacks Rank #1 "Strong Buys" free of charge. Many of these companies are almost unheard of by the general public and just starting to get noticed by Wall Street. They have been pinpointed by the Zacks system that nearly tripled the market from 1988 through 2015 with a stellar average gain of +26% per year. See these high-potential stocks free >>



SPRINT CORP (S): Free Stock Analysis Report

APPLE INC (AAPL): Free Stock Analysis Report

LULULEMON ATHLT (LULU): Free Stock Analysis Report

COSTCO WHOLE CP (COST): Free Stock Analysis Report

STARBUCKS CORP (SBUX): Free Stock Analysis Report

DAVE&BUSTRS ENT (PLAY): Free Stock Analysis Report

SOFTBANK CP (SFTBY): Free Stock Analysis Report

Original post

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.